We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

21 hedge funds and large institutions have $50.5M invested in Nuvation Bio Inc Warrants in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,106% more capital invested

Capital invested by funds: $4.19M → $50.5M (+$46.4M)

7.94% more ownership

Funds ownership: 1.41%9.35% (+7.9%)

9% less funds holding

Funds holding: 2321 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
Increased
2
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OCA
1
Octagon Capital Advisors
New York
$48.1M +$6.91M +27,018,464 +8,650%
EC
2
EcoR1 Capital
California
$1.7M
6CM
3
683 Capital Management
New York
$107K -$40.9K -159,921 -32%
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$85.3K
BCM
5
Boxer Capital Management
California
$85.3K
Franklin Resources
6
Franklin Resources
California
$58.4K
GCM
7
Greenland Capital Management
New York
$54.5K
DM
8
Deerfield Management
New York
$53.3K
LCM
9
Laurion Capital Management
New York
$53.3K
DC
10
Decheng Capital
California
$44K
SB
11
Samsara BioCapital
California
$42.7K
DCM
12
DME Capital Management
New York
$32K
RSCM
13
Rock Springs Capital Management
Maryland
$32K
BlackRock
14
BlackRock
New York
$30.4K
Citadel Advisors
15
Citadel Advisors
Florida
$23.5K -$104 -408 -0.6%
ACP
16
Acuta Capital Partners
California
$17.5K
LGM
17
Logos Global Management
California
$15.9K
Victory Capital Management
18
Victory Capital Management
Texas
$9.18K -$112 -440 -0.8%
IP
19
Intellectus Partners
California
$4.42K
UBS Group
20
UBS Group
Switzerland
$516 +$657 +2,571 +7,346%
Barclays
21
Barclays
United Kingdom
$410
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
-$4.24K -18,433 Closed
WAM
23
Wolverine Asset Management
Illinois
-$105 -458 Closed

NUVB.WS Hedge Fund Activity: Q1 2025 in Review

21 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q1 2025, worth a combined $50.5M — up 1,106% from $4.19M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NUVB.WS and 0 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Octagon Capital Advisors, adding an estimated $6.91M. The largest seller was 683 Capital Management, cutting an estimated $40.9K.

  • 21 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q1 2025, down from 23 in Q4 2024.
  • Funds reported $50.5M of Nuvation Bio Inc Warrants stock for Q1 2025, up 1,106% quarter-over-quarter.
  • 0 funds opened new Nuvation Bio Inc Warrants positions in Q1 2025 and 2 closed out, a net change of -2 holders.
  • The largest Nuvation Bio Inc Warrants buyer in Q1 2025 was Octagon Capital Advisors, an estimated $6.91M added.
  • The largest Nuvation Bio Inc Warrants seller in Q1 2025 was 683 Capital Management, an estimated $40.9K sold.

Based on aggregated 13F filings for Q1 2025.